Top 10 Life Science Startup Investors in Sweden (May 2026)

Portfolio highlights

• Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
• Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
• Value.Space — Space based risk assessments & monitoring

Portfolio highlights

• Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
• SNERPA Power — SNERPA Power develops intelligent energy services.
• Ellie.ai — Grasp your business needs and validate your product ideas before building your data pipelines. Use Ellie's conceptual data models and logical data models to design great data products.

Portfolio highlights

• Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Portfolio highlights

• LanguifyAI — Languify is an AI based language learning assistant which analyses, corrects, and tracks a user's spoken and written English across all platforms. The AI assistant prompts feedback and nudges that improve conversations in real-time that enable improvisation on the spot without any delay. It also enables users to learn at their own pace throughpersonalized learning plans and games designed to minimize repetition of errors.
• Granular Energy — Granular Energy provides solutions for managing and trading clean energy. Our tools have been developed to support the recent emergence of 24/7 time-stamped energy certificates as well as traditional "annual" certificates.
• Material Evolution — Material Evolution uses patented geopolymer technology and proprietary algorithms to create the most sustainable materials on the planet.Material Evolution’s first product is a cement mix made from 95% waste using its algorithm technology. Its smart concrete mix is 10X stronger, 5X more durable, and reduces carbon consumption by 85%. Mostimportantly, it’s economically viable for construction companies.

Portfolio highlights

• Digitail — Grow your practice, offer a modern client experience, and automate routine practice tasks with the proven all-in-one veterinary software.
• Mavenoid — Mavenoid is a computer software company that features a troubleshooting software that helps its users to locate malfunctions and provides guidelines on how to fix it. Its platform specializes in machine troubleshooting such as lawnmowers to cranes. The company was founded in 2017 and headquartered in Stockholms Lan, Sweden.
• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.

Portfolio highlights

• Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
• Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.
• Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations

Portfolio highlights

• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
• Valar Labs — AI to Make Oncologists Smarter
• Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.

Portfolio highlights

• Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
• EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
• Qvantum — Qvantum is driven by a passion for a sustainable future, built by a team of industry experts, and using groundbreaking innovation.

Portfolio highlights

• ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
• Mojo — Laboratory-grade AI-powered semen test at home. Test your sperm count, motility, volume and concentration with the Mojo kit. Check your fertility from home at low cost.
• Volta Greentech — Battling global warming by reducing methane emissions from cows

Portfolio highlights

• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
• Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.